{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T05:32:58Z","timestamp":1736400778649,"version":"3.32.0"},"reference-count":13,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2006,5,26]],"date-time":"2006-05-26T00:00:00Z","timestamp":1148601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold>A 17\u2010yr\u2010old girl in end\u2010stage renal failure was due to undergo living\u2010related pre\u2010emptive renal transplantation when she developed acute infectious mononucleosis (AIM) from Epstein\u2013Barr virus (EBV). In view of the risk of post\u2010transplant lymphoproliferative disorder (PTLD) we were unsure as to the optimal delay between AIM and renal transplantation. This report describes the process used to determine maturation of the immune response to EBV using a combination of serology, immunophenotyping and molecular viral load estimation. These tests showed that EBV had not been cleared and dialysis was instituted rather than proceed directly to transplantation. After EBV viral load became undetectable in the blood, living\u2010related donor was successfully performed 13\u2003months after AIM. With 42\u2010month post\u2010transplant follow up there has been no evidence of PTLD.<\/jats:p>","DOI":"10.1111\/j.1399-3046.2006.00535.x","type":"journal-article","created":{"date-parts":[[2006,5,26]],"date-time":"2006-05-26T09:32:49Z","timestamp":1148635969000},"page":"970-973","source":"Crossref","is-referenced-by-count":2,"title":["What delay should there be between primary infectious mononucleosis and renal transplantation?"],"prefix":"10.1111","volume":"10","author":[{"given":"L.","family":"Kerecuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Amlot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Riad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. J. A.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,5,26]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-003-1392-x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90994-2"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1996.d01-722.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/088282403763635401"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60684-8"},{"key":"e_1_2_5_7_2","first-page":"53","article-title":"T cell recognition of Epstein\u2013Barr virus associated lymphomas (Review)","volume":"13","author":"Rickinson AB","year":"1992","journal-title":"Cancer Surv"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199710150-00015"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(94)00147-9"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/978-1-4615-5381-6_108","article-title":"Biochemical basis for the impaired immune response in chronic renal failure","volume":"431","author":"Ruckermann K","year":"1998","journal-title":"Adv Exp Med Biol"},{"key":"e_1_2_5_11_2","first-page":"183","article-title":"T cells and B cells in chronic renal failure","volume":"16","author":"Descamps\u2010Latscha B","year":"1996","journal-title":"Semin Nephrol"},{"key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/JCM.38.2.613-619.2000","article-title":"High levels of Epstein\u2013Barr virus DNA in blood of solid\u2010organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders","volume":"38","author":"Baldanti F","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198804000-00011"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1399-0012.1996.tb00437.x","article-title":"Incidence of post\u2010transplant malignancy among 674 solid\u2010organ\u2010transplant recipients at a single center","volume":"10","author":"Mihalov ML","year":"1996","journal-title":"Clin Transplant"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3046.2006.00535.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3046.2006.00535.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T02:22:38Z","timestamp":1736389358000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3046.2006.00535.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,26]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1111\/j.1399-3046.2006.00535.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3046.2006.00535.x","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"type":"print","value":"1397-3142"},{"type":"electronic","value":"1399-3046"}],"subject":[],"published":{"date-parts":[[2006,5,26]]}}}